Medical Instruments & Supplies · Healthcare
CEO, Chairman, Board Member
2024-01-01–present
Chairman
Envista Holdings Corp (NVST)Board Member
Envista Holdings Corp (NVST)Equibles does not estimate personal net worth.
Get an email with a short summary when Envista Holdings Corp publishes a filing, an earnings call transcript or a press release.
Get NVST alertsPaul Keel is recorded as Chairman at Envista Holdings Corp (NVST) since August 19, 2026, Board Member at Envista Holdings Corp (NVST) since January 1, 2024 and CEO at Envista Holdings Corp (NVST). The newest filing on record that lists Paul Keel as Board Member at Envista Holdings Corp (NVST) is dated April 7, 2026. Envista Holdings Corp reported in an 8-K filed August 19, 2026 that Paul Keel was appointed Chair of the Board, effective August 19, 2026. Envista Holdings Corp reported in an 8-K filed April 15, 2024 that Paul Keel was appointed member of the Board of Directors, effective May 1, 2024. Envista Holdings Corp reported in an 8-K filed April 15, 2024 that Paul Keel was appointed President and Chief Executive Officer, effective May 1, 2024. The proxy statement of Envista Holdings Corp reports total compensation of $10,559,567 for Paul Keel in fiscal 2025, including a base salary of $1,100,000. Disclosed compensation is on record for 2 fiscal years. Paul Keel has spoken on 9 earnings calls and 2 other investor events across 1 company, most recently for Envista Holdings Corp on November 4, 2026. Envista Holdings Corp is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Envista Holdings Corp includes Andrew Chen (CIO), Mark Nance (General Counsel), Coree Thomas (Chief Accounting Officer) and 7 others.
“the Board appointed Paul Keel, the Company's President and Chief Executive Officer, to serve as Chair of the Board, effective August 19, 2026, succeeding Scott Huennekens, who will continue to serve as a director and as Lead Independent Director, as discussed in further detail below.”
“Pursuant to the Employment Agreement, Mr. Keel has also been appointed to join the Board of Directors of the Company (the “Board”) as of the Effective Date.”
“I'll start with an overview of the quarter, including strategic and operational progress made in support of our longer-term value creation plan. Eric will then take us through the numbers in more detail.”
“So more than everybody, Thanks for joining us. I am going to kick things off with three kind of opening comments to set the frame for the rest of the morning.”
“So as you mentioned, Eric and I both joined Invista a little over two years ago. We grew up in dental, so in and out of dental for 20-something years. And we wanted to come back to dental.”
“On today's call, I'll kick us off with a summary of our Q2 performance.”
“On today's call I'll kick us off with some opening thoughts on our Q4 and 2025 performance, our progress implementing the value creation plan that we communicated in March of last year, and our guidance for 2026.”
2026-08-19–present
2024-01-01–present
Last confirmed April 7, 2026
Medical Instruments & Supplies · Healthcare
CEO, Chairman, Board Member
2024-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Envista Holdings Corp (NVST) | President & CEO | $1,100,000 | $10,559,567 |
| 2024 | Envista Holdings Corp (NVST) | President & CEO, from May 1, 2024 | $1,100,000 | $24,236,357 |